Form 4: Ambiq Micro CTO Executes Stock Options and Sales
Statement of Changes in Beneficial Ownership
Chief Technology Officer Scott McLean exercised stock options and sold shares of Ambiq Micro common stock.
Summary
- Scott McLean, Chief Technology Officer of Ambiq Micro, exercised options for 18,300 shares of common stock at an exercise price of $8.12.
- Following the exercise, the reporting person sold a total of 10,200 shares on May 14, 2026, at weighted average prices ranging from $68.62 to $70.50.
- The reporting person retains beneficial ownership of 211,226 shares of common stock following these transactions.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as it represents routine insider activity rather than a strategic shift or performance-related disclosure.
Positives
- The executive maintains a significant equity stake of 211,226 shares, indicating continued alignment with shareholder interests.
Negatives
- The transaction involves the liquidation of a portion of the executive's holdings, which may be perceived as a reduction in long-term exposure.
Risks
- Future share price volatility could impact the value of remaining unexercised options and held shares.
Future Outlook
No specific forward-looking guidance regarding company performance was provided in this filing.
Industry Context
StockSavvy.ai notes that insider selling following option exercises is a standard practice for liquidity and tax management among technology executives and does not necessarily reflect a change in company outlook.
Comparison to Industry Standards
- The exercise and sale pattern is consistent with standard executive compensation and liquidity management practices observed in the semiconductor industry.
Stakeholder Impact
- Minimal impact on shareholders as the transactions represent standard executive liquidity events.
Next Steps
- Continued monitoring of future Form 4 filings for further insider activity.
Key Dates
| Date | Description |
|---|---|
| 05/14/2026 | Date of initial option exercise and share sales. |
| 05/15/2026 | Date of secondary option exercise. |
| 05/18/2026 | Date of filing. |
Keywords
Ambiq Micro, AMBQ, Insider Trading, Form 4, Stock Options, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.